Volume 27, Issue 1 (Avicenna Journal of Clinical Medicine-Spring 2020)                   Avicenna J Clin Med 2020, 27(1): 13-20 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sobhan M, Nazari F, Mohammadi Y. Correlation between Seborrheic Dermatitis and Metabolic Syndrome in Patients Referred to Sina Hospital of Hamadan. Avicenna J Clin Med 2020; 27 (1) :13-20
URL: http://sjh.umsha.ac.ir/article-1-2021-en.html
1- , mreza_sobhan@yahoo.com
Abstract:   (3805 Views)
Background & Objectives: Seborrheic dermatitis is a chronic inflammatory skin disease. Inflammation is one of the components of metabolic syndrome and many inflammatory cytokines play a critical role in this disease. The aim of this study was to investigate correlation between seborrheic dermatitis and metabolic syndrome.
Materials & Methods: In this case- control study 39 seborrheic dermatitis patients who referred to Sina Hospital of Hamadan as case group and 39 age and sex matched healthy individuals as control group were compared in terms of metabolic syndrome. Statistical analysis was performed using version 16.0 (SPSS Inc. Chicago, IL).
Results: High-density lipoprotein (HDL) levels in the patient group were statistically significantly lower than in the controls (in women P=0.046 and in men P=0.044). Mean of triglyceride, cholesterol, low-density lipoprotein(LDL), fasting blood glucose (FBS), systolic and diastolic blood pressure and waist circumference in case group were more than in control group but just systolic blood pressure and waist circumference were statistically significant (P<0.05). In case group 20.5% and in control group 7.7% were afflicted metabolic syndrome which was not statistically significant (P=0.104).
Conclusion: Some significant parameters of metabolic syndrome in seborrheic dermatitis patients may be a predictive factor for screening.
Full-Text [PDF 1087 kb]   (1469 Downloads)    
Type of Study: Original | Subject: Dermatology

1. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91(3):185-90. PMID: 25822272
2. Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol. 2000;1(2):75-80. PMID: 11702314 DOI: 10.2165/00128071-200001020-00001
3. Gupta AK, Bluhm R, Cooper EA, Summerbell RC, Batra R. Seborrheic dermatitis. Dermatol Clin. 2003;21(3):401-12. PMID: 12956195 DOI: 10.1111/j.1468-3083.2004.00693.x
4. Gupta A, Bluhm R, Barlow J, Fleischer AB Jr, Feldman SR. Prescribing practices for seborrheic dermatitis vary with the physician's specialty: implications for clinical practice. J Dermatol Treat. 2004;15(4):208-13. PMID: 15764032 DOI: 10.1080/09546630410032430
5. Vincent SF, Casady M, Chacon A, Gaspari AA. Skin diseases in primary immunodeficiencies. Skin diseases in the immunosuppressed. New York: Springer; 2018. P. 35-51.
6. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25(1):106-41. PMID: 22232373 DOI: 10.1128/CMR.00021-11
7. Viodé C, Lejeune O, Turlier V, Rouquier A, Casas C, Mengeaud V, et al. Cathepsin S, a new pruritus biomarker in clinical dandruff/seborrhoeic dermatitis evaluation. Exp Dermatol. 2014;23(4):274-5. PMID: 24690038 DOI: 10.1111/exd.12357
8. Schwartz JR, Messenger AG, Tosti A, Todd G, Hordinsky M, Hay RJ, et al. A comprehensive pathophysiology of dandruff and seborrheic dermatitis-towards a more precise definition of scalp health. Acta Derm Venereol. 2013;93(2):131-7. PMID: 22875203 DOI: 10.2340/00015555-1382
9. Burton JL, Rook A, Wilkinson DS. Eczema, lichen simplex, erythroderma and prurigo. Textbook of dermatology. Hoboken, NJ: Wiley-Blackwell Science; 2010. P. 29-34.
10. Imamoglu B, Hayta SB, Guner R, Akyol M, Ozcelik S. Metabolic syndrome may be an important comorbidity in patients with seborrheic dermatitis. Arch Med Sci Atheroscler Dis. 2016;1(1):e158-61. PMID: 28905039 DOI: 10.5114/amsad.2016.65075
11. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-35. PMID: 17052489 DOI: 10.1016/j.jaad.2006.08.040
12. Meziane M, Kelati A, Najdi A, Berraho A, Nejjari C, Mernissi FZ. Metabolic syndrome in Moroccan patients with psoriasis. Int J Dermatol. 2016;55(4):396-400. PMID: 26712557 DOI: 10.1111/ijd.12623
13. Fröhlich M, Sund M, Löwel H, Imhof A, Hoffmeister A, Koenig W. Independent association of various smoking characteristics with markers of systemic inflammation in men: results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J. 2003;24(14):1365-72. PMID: 12871694 DOI: 10.1016/s0195-668x(03)00260-4
14. Hjelstuen A, Anderssen SA, Holme I, Seljeflot I, Klemsdal TO. Markers of inflammation are inversely related to physical activity and fitness in sedentary men with treated hypertension. Am J Hypertens. 2006;19(7):669-75. PMID: 16814119 DOI: 10.1016/j.amjhyper.2005.11.012
15. Lin CC, Kardia SL, Li CI, Liu CS, Lai MM, Lin WY, et al. The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population. BMC Public Health. 2010;10(1):579. PMID: 20875142 DOI: 10.1186/1471-2458-10-579
16. Jung CH, Lee WY, Kim SY, Shin HS, Dai Kim H, Rhee EJ, et al. The risk of metabolic syndrome according to the high-sensitivity C-reactive protein in apparently healthy Koreans. Int J Cardiol. 2008;129(2):266-71. PMID: 17988754 DOI: 10.1016/j.ijcard.2007.07.092
17. Qureshi MM, Singer MR, Moore LL. A cross-sectional study of food group intake and C-reactive protein among children. Nutr Metab. 2009;6(1):40. PMID: 19822004 DOI: 10.1186/1743-7075-6-40
18. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391-7. PMID: 12551861 DOI: 10.1161/01.cir.0000055014.62083.05
19. Lee WY, Park JS, Noh SY, Rhee EJ, Sung KC, Kim BS, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol. 2004;97(1):101-6. PMID: 15336815 DOI: 10.1016/j.ijcard.2003.08.016
20. Tannock LR, O’brien KD, Knopp RH, Retzlaff B, Fish B, Wener MH, et al. Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation. 2005;111(23):3058-62. PMID: 15939816 DOI: 10.1161/CIRCULATIONAHA.104.506188
21. Poitou C, Coussieu C, Rouault C, Coupaye M, Cancello R, Bedel JF, et al. Serum amyloid A: a marker of adiposity‐induced low‐grade inflammation but not of metabolic status. Obesity. 2006;14(2):309-18. PMID: 16571858 DOI: 10.1038/oby.2006.40
22. Liu J, Young TK, Zinman B, Harris SB, Connelly PW, Hanley AJ. Lifestyle variables, non‐traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Obesity. 2006;14(3):500-8. PMID: 16648622 DOI: 10.1038/oby.2006.65
23. Zuliani G, Volpato S, Galvani M, Blè A, Bandinelli S, Corsi AM, et al. Elevated C-reactive protein levels and metabolic syndrome in the elderly: the role of central obesity: data from the Inchianti study. Atherosclerosis. 2009;203(2):626-32. PMID: 18845301 DOI: 10.1016/j.atherosclerosis.2008.07.038
24. Fizelova M, Jauhiainen R, Kangas AJ, Soininen P, Ala-Korpela M, Kuusisto J, et al. Differential associations of inflammatory markers with insulin sensitivity and secretion: the prospective METSIM study. J Clin Endocrinol Metab. 2017;102(9):3600-9. PMID: 28911155 DOI: 10.1210/jc.2017-01057
25. Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Invest Dermatol. 2015;3(2):1-22. PMID: 27148560 DOI: 10.13188/2373-1044.1000019
26. Berk T, Scheinfeld N. Seborrheic dermatitis. P T. 2010;35(6):348-52. PMID: 20592880
27. Newcomer JW. Metabolic syndrome and mental illness. Am J Manag Care. 2007;13(Suppl 7):S170-7. PMID: 18041878
28. Stefanadi EC, Dimitrakakis G, Antoniou CK, Challoumas D, Punjabi N, Dimitrakaki IA, et al. Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients. Diabetol Metab Syndr. 2018;10(1):9. PMID: 29483947 DOI: 10.1186/s13098-018-0311-z
29. Rodríguez-Zúñiga MJ, García-Perdomo HA. Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome. J Am Acad Dermatol. 2017;77(4):657-66. PMID: 28917453 DOI: 10.1016/j.jaad.2017.04.1133
30. Ghaderi R, Kazemi T, Zarban A, Erfanian M. The relationship of plasma antioxidants and serum lipid levels with seborrheic dermatitis (SD): a case-control study. J Adv Med Biomed Res. 2007;15(60):83-92. [Persian]
31. Gordon SM, Hofmann S, Askew DS, Davidson WS. High density lipoprotein: it's not just about lipid transport anymore. Trends Endocrinol Metab. 2011;22(1):9-15. DOI: 10.1016/j.tem.2010.10.001
32. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11(8):327-32. PMID: 10996528 DOI: 10.1016/s1043-2760(00)00301-5
33. Mirza MS. Obesity, visceral fat, and NAFLD: Querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol. 2011;2011:592404. PMID: 21991518 DOI: 10.5402/2011/592404
34. Nakamizo S, Honda T, Kabashima K. Obesity and inflammatory skin diseases. Trends Immunother. 2017;1(2):67-74. DOI: 10.24294/ti.v1.i2.98
35. Shenoy C, Shenoy MM, Rao GK. Dyslipidemia in dermatological disorders. N AM J Med Sci. 2015;7(10):421-8. PMID: 26713286 DOI: 10.4103/1947-2714.168657
36. Linder D, Dreiher J, Zampetti A, Sampogna F, Cohen A. Seborrheic dermatitis and hypertension in adults: a cross‐sectional study. J Eur Acad Dermatol Venereol. 2014;28(11):1450-5. PMID: 24267636 DOI: 10.1111/jdv.12310

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Avicenna Journal of Clinical Medicine

Designed & Developed by : Yektaweb